High throughput proteomic strategies for identifying tumour-associated antigens

被引：66

作者：

Gunawardana, C. Geeth

Diamandis, Eleftherios P. ^{[1
]}

机构：

[1] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada

[2] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada

来源：

CANCER LETTERS | 2007年 / 249卷 / 01期

基金：

加拿大自然科学与工程研究理事会;

关键词：

tumour-associated antigens; SEREX; SERPA; protein microarray;

D O I：

10.1016/j.canlet.2007.01.002

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Tumours elicit an immune response in the host organism and this area has been studied for decades. Initially, tumour-associated antigens were studied by examining a few proteins at a time using techniques such as 1-D SDS-PAGE and sandwich ELISAs. Now, however, with the development of high-throughput strategies, multiple potential antigens in a single experiment could be uncovered. The prevailing view is that these antigens can be used as biosensors for cancers. In addition, some of these antigens may indeed be used as targets for immunotherapy. SEREX, SERPA, and protein microarray technology have been the three domimant strategies employed to identify tumour-associated antigens. In this mini-review, we aim to describe these three techniques and provide their advantages and disadvantages. In addition, we aim to address some of the challenges of cancer immunomics. (C) 2007 Elsevier Ireland Ltd. All rights reserved.

引用

页码：110 / 119

页数：10

共 37 条

[1] The sentinel within: Exploiting the immune system for cancer biomarkers [J].